Efficacy of Leuprorelin 3-Month Depot (11.25 mg) Compared to 1-Month Depot (3.75 mg) for Central Precocious Puberty in Chinese Girls: A Prospective Cohort Study

OBJECTIVE: A 3-month depot of leuprorelin acetate (LA) was introduced in China in July 2020. However, the clinical experience is limited. The purpose of this study was to compare the efficacy of a LA 11.25 mg 3-month depot with that of a 3.75 mg 1-month depot in suppressing pubertal development for...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Jianmei, Song, Qijun, Gao, Shuo, Gao, Yuye, Shang, Xiaohong, Li, Guimei, Sun, Yan, Luo, Xiaoping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9800096/
https://www.ncbi.nlm.nih.gov/pubmed/36590006
http://dx.doi.org/10.1155/2022/1043293

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9800096/
https://www.ncbi.nlm.nih.gov/pubmed/36590006
http://dx.doi.org/10.1155/2022/1043293

Ejemplares similares